Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 38 Neoplasm Metastasis 14 Liver Neoplasms 11 Colorectal Neoplasms 11 Cholangiocarcinoma 9 Pancreatic Neoplasms 8 Lung Neoplasms 8 Colonic Neoplasms 7 Breast Neoplasms 7 Thyroid Nodule 6 Recurrence 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 6 Thyroid Neoplasms 5 Rectal Neoplasms 4 Neoplasms 4 Esophageal Neoplasms 4 Prostatic Neoplasms 3 Pain 3 Kidney Neoplasms 3 Barrett Esophagus 3 Agnosia 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Leiomyoma 2 Hyperaldosteronism 2 Gallbladder Neoplasms 2 Cancer Pain 2 Bile Duct Neoplasms 2 Adrenocortical Adenoma 2

Interventions

Pemetrexed 9 Drug Therapy 9 osimertinib 7 Radiotherapy 6 Carboplatin 6 anlotinib 5 Radiosurgery 5 aflutinib 4 Gefitinib 4 Docetaxel 4 Cisplatin 4 tislelizumab 3 pembrolizumab 3 icotinib 3 Vinorelbine 3 Paclitaxel 3 Gemcitabine 3 Erlotinib Hydrochloride 3 toripalimab 2 dacomitinib 2 camrelizumab 2 apatinib 2 Tyrosine Kinase Inhibitors 2 Thalidomide 2 Surgical Procedures, Operative 2 S 1 (combination) 2 Platinum 2 Liquid Biopsy 2 Immune Checkpoint Inhibitors 2 Chemotherapy, Adjuvant 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × NSCLC × Radiofrequency Ablation × Clear all

NCT01105182 2010-04-16

FACPT

The First Affiliated Hospital of Guangzhou Medical University

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡